₹151
(Inclusive of all Taxes)
₹22.6 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
Composition :
CHLORTHALIDONE-6.25MG + METOPROLOL-50MG
Manufacturer/Marketer :
Ipca Laboratories Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
Critical
chlorthalidoneAminolevulinic acid
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with CTD-M 6.25/50 Tablet:
Co-administration of CTD-M 6.25/50 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking CTD-M 6.25/50 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of CTD-M 6.25/50 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking CTD-M 6.25/50 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
chlorthalidoneAminolevulinic acid
Severe
How does the drug interact with CTD-M 6.25/50 Tablet:
Co-administration of Aminolevulinic acid and CTD-M 6.25/50 Tablet may increase the risk of severe sunburn.
How to manage the interaction:
Taking CTD-M 6.25/50 Tablet with Aminolevulinic acid together can possibly result in an interaction, but it can be taken if a doctor has advised it. If you notice that your skin is very sensitive to sunlight or if you have a really bad sunburn, it's important to contact your doctor right away. Do not discontinue any medications without consulting a doctor.
Co-administration of Aminolevulinic acid and CTD-M 6.25/50 Tablet may increase the risk of severe sunburn.
How to manage the interaction:
Taking CTD-M 6.25/50 Tablet with Aminolevulinic acid together can possibly result in an interaction, but it can be taken if a doctor has advised it. If you notice that your skin is very sensitive to sunlight or if you have a really bad sunburn, it's important to contact your doctor right away. Do not discontinue any medications without consulting a doctor.
How does the drug interact with CTD-M 6.25/50 Tablet:
Co-administration of CTD-M 6.25/50 Tablet with ziprasidone can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, CTD-M 6.25/50 Tablet can be taken with ziprasidone if prescribed by the doctor. but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, weakness, tiredness, drowsiness, confusion, muscle pain, cramps, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
Co-administration of CTD-M 6.25/50 Tablet with ziprasidone can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, CTD-M 6.25/50 Tablet can be taken with ziprasidone if prescribed by the doctor. but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, weakness, tiredness, drowsiness, confusion, muscle pain, cramps, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with CTD-M 6.25/50 Tablet:
Co-administration of Tizanidine and CTD-M 6.25/50 Tablet may show additive effects and increase the risk of low blood pressure.
How to manage the interaction:
Although there is an interaction, CTD-M 6.25/50 Tablet can be taken with tizanidine if prescribed by the doctor. If you experience headache, dizziness, palpitations, or sweating, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Tizanidine and CTD-M 6.25/50 Tablet may show additive effects and increase the risk of low blood pressure.
How to manage the interaction:
Although there is an interaction, CTD-M 6.25/50 Tablet can be taken with tizanidine if prescribed by the doctor. If you experience headache, dizziness, palpitations, or sweating, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with CTD-M 6.25/50 Tablet:
Co-administration of CTD-M 6.25/50 Tablet together with lithium can increase the effects of lithium.
How to manage the interaction:
Although there is a interaction between CTD-M 6.25/50 Tablet and lithium, but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience diarrhea, vomiting, drowsiness, shaking of hands and legs, thirst, increased urination, lack of coordination, or muscle weakness. Do not discontinue any medications without consulting a doctor.
Co-administration of CTD-M 6.25/50 Tablet together with lithium can increase the effects of lithium.
How to manage the interaction:
Although there is a interaction between CTD-M 6.25/50 Tablet and lithium, but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience diarrhea, vomiting, drowsiness, shaking of hands and legs, thirst, increased urination, lack of coordination, or muscle weakness. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with CTD-M 6.25/50 Tablet:
Coadministration of CTD-M 6.25/50 Tablet with amiodarone may increase the risk of abnormal heart rhythms.
How to manage the interaction:
Although taking CTD-M 6.25/50 Tablet with amiodarone may cause an interaction, it is safe to do so if your doctor has prescribed it. If you have a cardiac problem or electrolyte imbalances, you may be more vulnerable. If you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or a rapid heartbeat, consult a doctor. Do not stop taking any medications without visiting a doctor.
Coadministration of CTD-M 6.25/50 Tablet with amiodarone may increase the risk of abnormal heart rhythms.
How to manage the interaction:
Although taking CTD-M 6.25/50 Tablet with amiodarone may cause an interaction, it is safe to do so if your doctor has prescribed it. If you have a cardiac problem or electrolyte imbalances, you may be more vulnerable. If you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or a rapid heartbeat, consult a doctor. Do not stop taking any medications without visiting a doctor.
Severe
How does the drug interact with CTD-M 6.25/50 Tablet:
Co-administration of CTD-M 6.25/50 Tablet with pimozide can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, CTD-M 6.25/50 Tablet can be taken with pimozide if prescribed by the doctor. Consult the prescriber if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with pimozide. Also, let the doctor know if you experience signs of electrolyte disturbance, such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
Co-administration of CTD-M 6.25/50 Tablet with pimozide can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, CTD-M 6.25/50 Tablet can be taken with pimozide if prescribed by the doctor. Consult the prescriber if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with pimozide. Also, let the doctor know if you experience signs of electrolyte disturbance, such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
chlorthalidoneDroperidol
Severe
How does the drug interact with CTD-M 6.25/50 Tablet:
Taking Droperidol can make CTD-M 6.25/50 Tablet less effective in lowering blood pressure.
How to manage the interaction:
Taking CTD-M 6.25/50 Tablet with Droperidol together can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away. These symptoms include an irregular heart rhythm, severe or long-lasting diarrhea or vomiting, complications, sudden dizziness or lightheadedness, fainting, difficulty breathing, heart palpitations, weakness, feeling sleepy or confused, muscle pain, and feeling nauseous or vomiting. Do not stop using any medications without first talking to your doctor.
Taking Droperidol can make CTD-M 6.25/50 Tablet less effective in lowering blood pressure.
How to manage the interaction:
Taking CTD-M 6.25/50 Tablet with Droperidol together can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away. These symptoms include an irregular heart rhythm, severe or long-lasting diarrhea or vomiting, complications, sudden dizziness or lightheadedness, fainting, difficulty breathing, heart palpitations, weakness, feeling sleepy or confused, muscle pain, and feeling nauseous or vomiting. Do not stop using any medications without first talking to your doctor.
How does the drug interact with CTD-M 6.25/50 Tablet:
Taking CTD-M 6.25/50 Tablet can make the body eliminate Arsenic trioxide faster, leading to lower levels in the blood and potentially reducing its effectiveness.
How to manage the interaction:
Co-administration of CTD-M 6.25/50 Tablet with Arsenic trioxide can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away: your heart beating irregularly, feeling dizzy or lightheaded, fainting, having a fast or pounding heartbeat, feeling weak or drowsy, being confused, experiencing muscle pain, or feeling nauseous or vomiting. Do not discontinue any medications without consulting a doctor.
Taking CTD-M 6.25/50 Tablet can make the body eliminate Arsenic trioxide faster, leading to lower levels in the blood and potentially reducing its effectiveness.
How to manage the interaction:
Co-administration of CTD-M 6.25/50 Tablet with Arsenic trioxide can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away: your heart beating irregularly, feeling dizzy or lightheaded, fainting, having a fast or pounding heartbeat, feeling weak or drowsy, being confused, experiencing muscle pain, or feeling nauseous or vomiting. Do not discontinue any medications without consulting a doctor.
MetoprololElvitegravir
Severe
How does the drug interact with CTD-M 6.25/50 Tablet:
Taking elvitegravir may increase the metabolism of CTD-M 6.25/50 Tablet.
How to manage the interaction:
Although there may be an interaction, CTD-M 6.25/50 Tablet can be taken with Elvitegravir if prescribed by the doctor. Consult the doctor if you experience dizziness, palpitations, fainting, slow or fast pulse, or irregular heartbeats. Do not discontinue any medications without talking to your doctor.
Taking elvitegravir may increase the metabolism of CTD-M 6.25/50 Tablet.
How to manage the interaction:
Although there may be an interaction, CTD-M 6.25/50 Tablet can be taken with Elvitegravir if prescribed by the doctor. Consult the doctor if you experience dizziness, palpitations, fainting, slow or fast pulse, or irregular heartbeats. Do not discontinue any medications without talking to your doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
CTD-M 6.25/50 Tablet Substitute
Product Substitutes
Alcohol
Unsafe
CTD-M 6.25/50 Tablet may interact with alcohol and worsen the condition.
Pregnancy
Consult your doctor
CTD-M 6.25/50 Tablet is a category C drug. CTD-M 6.25/50 Tablet should not be used in pregnant women unless clinically required and when benefits outweigh the risks.
Breast Feeding
Consult your doctor
CTD-M 6.25/50 Tablet should be given to breastfeeding mothers only if clinically needed.
Driving
Unsafe
CTD-M 6.25/50 Tablet may cause dizziness. So, refrain from activities that require you to stay alert such as driving and operating heavy machinery.
Liver
Caution
CTD-M 6.25/50 Tablet should be used with caution in patients with severe liver diseases. Dose adjustments may be necessary.
Kidney
Caution
CTD-M 6.25/50 Tablet should be used with caution in patients with severe kidney diseases. Regular monitoring of serum electrolyte levels and dose adjustments are necessary.
Children
Unsafe
CTD-M 6.25/50 Tablet is not recommended for use in children.
Have a query?
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
